Zogenix Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (35)

View All

Latest Posts

About This Stock More About This Stock
The Week Ahead In Biotech (Jan. 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, & More
Article By: Benzinga
Sunday, January 23, 2022 2:45 PM EDT
Biotech stocks pulled back yet again during the week ending Jan. 21, with the sector retreating along with the broader market. The news flow tapered off following the frenetic pace of the week that encompassed the JPM Healthcare conference.
In this article: ABT, JNJ, RHHBY, UCBJY, ZGNX, VRTX, ZLAB, CUE, DCPH, ETON
Read
18 Key Biopharma Catalysts To Keep An Eye On In Q3
Article By: Benzinga
Saturday, July 10, 2021 3:54 PM EDT
Biopharma stocks underperformed in the first half of 2021, and several of these stocks could be in for a rebound in the coming months. Here is a look at some catalysts for the biopharam sector in the coming months.
In this article: ZGNX, XENE, AERI, RVNC, ZYNE, CLSD, RGNX, KALV, ACER, VRCA
Read
FANG Stocks & Nike Politics Now Impacting Stock Charts
Video By: Robert Desmond
Thursday, September 6, 2018 9:52 AM EDT
A discussion on the FANG stocks, on Nike and their decisions to allow their left-leaning politics to influence their businesses.
In this video: DDE, NKE, QQQ, ZGNX, AMZN, GLD, SPY, USO, UUP, META, GOOGL, GNMX
Watch
2018 Outlook – Biotech Bonanza: Biotech Stocks To Keep Shining
Article By: Tarun Chandra, CFA
Sunday, December 17, 2017 11:58 AM EDT
Biotech is not an easy sector to invest in - 95 percent of the oncology drugs that enter clinical trials fail. But that is no reason to ignore biotechs. We believe biotech stocks in 2018 will deliver double-digit returns of around 20%.
In this article: ALNY, ALXN, ABEO Also: ASH, ARNA, AMGN, BIIB, ANAB, SPPI, ZGNX, NKTR, EXAS, SAGE, HALO, SGMO, DVAX, INSM, XBI, JUNO, ESPR, LOXO, RVNC, LABD, LABU, BPMC, MRTX, NVS, CLLS, BLUE, BMY, INCY, CELG, GILD, VRTX, REGN
Read
Will Proper Regulation Promote Cannabis Industry Growth?
Article By: Maithya Kitonyi
Wednesday, October 4, 2017 10:42 PM EDT
In most countries, cannabis is still classified under the category of drugs with no medical value and a substantial risk of abuse, but medical research has challenged this as companies continue to develop cannabinoid products for various treatments.
In this article: ZGNX, GWPH
Read
All Posts

Latest Tweets for $ZGNX

No tweets yet!

PARTNER HEADLINES